Xorphanol

Source: Wikipedia, the free encyclopedia.
Xorphanol
Structural formula
Ball-and-stick model
Clinical data
ATC code
  • none
Identifiers
  • N-(Cyclobutylmethyl)-8β-methyl-6-methylenemorphinan-3-ol
JSmol)
  • C[C@H]1CC(=C)C[C@@]23[C@@H]1[C@@H](CC4=C2C=C(C=C4)O)N(CC3)CC5CCC5
  • InChI=1S/C23H31NO/c1-15-10-16(2)22-21-11-18-6-7-19(25)12-20(18)23(22,13-15)8-9-24(21)14-17-4-3-5-17/h6-7,12,16-17,21-22,25H,1,3-5,8-11,13-14H2,2H3/t16-,21+,22-,23+/m0/s1 ☒N
  • Key:AZJPPZHRNFQRRE-AZIXLERZSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Xorphanol (

INN) (developmental code name TR-5379 or TR-5379M), also known as xorphanol mesylate (USAN), is an opioid analgesic of the morphinan family that was never marketed.[1][2][3]

Xorphanol is a mixed

opioid-dependent individuals).[3][10] The drug has also been found to act as an agonist of the δ-opioid receptor (Ki = 1.0 nM; IC50 = 8 nM; Imax = 76%).[11]

Xorphanol produces potent analgesia, and was originally claimed to possess a minimal potential for

euphoria, and this was the subject of a lawsuit between the drug's inventors and the company to which they had licensed the marketing rights, which claimed that these side effects had not been revealed to them during the license negotiations.[16]
As a result of this dispute, the drug was never marketed commercially.

See also

References